Show simple item record

dc.contributor.authorChappel, JAen_US
dc.contributor.authorRogers, WOen_US
dc.contributor.authorHoffman, SLen_US
dc.contributor.authorKang, ASen_US
dc.date.accessioned2021-06-01T16:47:33Z
dc.date.available2004-07-29en_US
dc.date.issued2004-07-29en_US
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/72198
dc.description.abstractBACKGROUND: The circumsporozoite surface protein is the primary target of human antibodies against Plasmodium falciparum sporozoites, these antibodies are predominantly directed to the major repetitive epitope (Asn-Pro-Asn-Ala)n, (NPNA)n. In individuals immunized by the bites of irradiated Anopheles mosquitoes carrying P. falciparum sporozoites in their salivary glands, the anti-repeat response dominates and is thought by many to play a role in protective immunity. METHODS: The antibody repertoire from a protected individual immunized by the bites of irradiated P. falciparum infected Anopheles stephensi was recapitulated in a phage display library. Following affinity based selection against (NPNA)3 antibody fragments that recognized the PfCSP repeat epitope were rescued. RESULTS: Analysis of selected antibody fragments implied the response was restricted to a single antibody fragment consisting of VH3 and VkappaI families for heavy and light chain respectively with moderate affinity for the ligand. CONCLUSION: The dissection of the protective antibody response against the repeat epitope revealed that the response was apparently restricted to a single VH/VL pairing (PfNPNA-1). The affinity for the ligand was in the microM range. If anti-repeat antibodies are involved in the protective immunity elicited by exposure to radiation attenuated P. falciparum sporozoites, then high circulating levels of antibodies against the repeat region may be more important than intrinsic high affinity for protection. The ability to attain and sustain high levels of anti-(NPNA)n will be one of the key determinants of efficacy for a vaccine that relies upon anti-PfCSP repeat antibodies as the primary mechanism of protective immunity against P. falciparum.en_US
dc.format.extent28 - ?en_US
dc.languageengen_US
dc.relation.ispartofMalar Jen_US
dc.rightsThis is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
dc.subjectAnimalsen_US
dc.subjectAntibodies, Monoclonalen_US
dc.subjectAntibodies, Protozoanen_US
dc.subjectAntibody Affinityen_US
dc.subjectAntibody Specificityen_US
dc.subjectAntigens, Protozoanen_US
dc.subjectEnzyme-Linked Immunosorbent Assayen_US
dc.subjectEpitopesen_US
dc.subjectFluorescent Antibody Technique, Indirecten_US
dc.subjectGene Expression Regulationen_US
dc.subjectGene Libraryen_US
dc.subjectHumansen_US
dc.subjectImmunoglobulinsen_US
dc.subjectMiceen_US
dc.subjectPlasmodium falciparumen_US
dc.subjectProtozoan Proteinsen_US
dc.subjectReverse Transcriptase Polymerase Chain Reactionen_US
dc.titleMolecular dissection of the human antibody response to the structural repeat epitope of Plasmodium falciparum sporozoite from a protected donor.en_US
dc.typeArticle
dc.rights.holder© 2004 Chappel et al; licensee BioMed Central Ltd.
dc.identifier.doi10.1186/1475-2875-3-28en_US
pubs.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/15283866en_US
pubs.notesNot knownen_US
pubs.publication-statusPublished onlineen_US
pubs.volume3en_US
dcterms.dateAccepted2004-07-29en_US
rioxxterms.funderDefault funderen_US
rioxxterms.identifier.projectDefault projecten_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record